These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 16399649

  • 1. Localized amyloidosis: a survey of 35 French cases.
    Paccalin M, Hachulla E, Cazalet C, Tricot L, Carreiro M, Rubi M, Grateau G, Roblot P.
    Amyloid; 2005 Dec; 12(4):239-45. PubMed ID: 16399649
    [Abstract] [Full Text] [Related]

  • 2. [Therapy options in systemic AL-amyloidosis with renal involvement].
    Hetzel GR, Schneider P, Mondry A, Heering P, Heyll A, Grabensee B.
    Dtsch Med Wochenschr; 2000 Aug 25; 125(34-35):997-1002. PubMed ID: 11004911
    [Abstract] [Full Text] [Related]

  • 3. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV, Gertz MA, Kyle RA.
    Cancer; 1998 Apr 15; 82(8):1501-5. PubMed ID: 9554527
    [Abstract] [Full Text] [Related]

  • 4. An unusual case of primary systemic amyloidosis.
    Ambrosone L, Mansi L, Salvatore T, Marino F, Orabona P, Rambaldi A, Rambaldi PF, Rambaldi M.
    J Eur Acad Dermatol Venereol; 1998 Jan 15; 10(1):53-7. PubMed ID: 9552758
    [Abstract] [Full Text] [Related]

  • 5. Amyloidosis of the larynx: a clinicopathologic study of 11 cases.
    Thompson LD, Derringer GA, Wenig BM.
    Mod Pathol; 2000 May 15; 13(5):528-35. PubMed ID: 10824924
    [Abstract] [Full Text] [Related]

  • 6. Fine-needle aspiration of abdominal fat pad for amyloid detection: a clinically useful test?
    Ansari-Lari MA, Ali SZ.
    Diagn Cytopathol; 2004 Mar 15; 30(3):178-81. PubMed ID: 14986298
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
    Comenzo RL.
    Contrib Nephrol; 2007 Mar 15; 153():195-210. PubMed ID: 17075231
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.
    Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM.
    N Engl J Med; 1997 Apr 24; 336(17):1202-7. PubMed ID: 9110907
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis.
    Tazawa K, Katoh N, Shimojima Y, Matsuda M, Ikeda S.
    Amyloid; 2009 Dec 24; 16(4):243-5. PubMed ID: 19922338
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A case of primary amyloidosis].
    Ardashev VN, Potekhin NP, Rukavitsyn OA, Borisov AG, Malysheva SA.
    Klin Med (Mosk); 2006 Dec 24; 84(6):56-9. PubMed ID: 16875072
    [Abstract] [Full Text] [Related]

  • 18. Characteristics and long-term outcome of patients with systemic immunoglobulin light-chain amyloidosis.
    Nelson LM, Gustafsson F, Gimsing P.
    Acta Haematol; 2015 Dec 24; 133(4):336-46. PubMed ID: 25531398
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.